Graham Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.9K | Sell |
85,633
-54,431
| -39% | -$61K | ﹤0.01% | 1165 |
|
|
2025
Q1 | $111K | Buy |
140,064
+117,722
| +527% | +$93K | ﹤0.01% | 1170 |
|
|
2024
Q4 | $36.9K | Buy |
+22,342
| New | +$36.9K | ﹤0.01% | 1159 |
|
|
2024
Q3 | – | Sell |
-11,565
| Closed | -$37.9K | – | 1134 |
|
|
2024
Q2 | $37.9K | Buy |
+11,565
| New | +$37.9K | ﹤0.01% | 965 |
|
|
2023
Q4 | – | Sell |
-21,690
| Closed | -$46K | – | 1071 |
|
|
2023
Q3 | $46K | Sell |
21,690
-120,711
| -85% | -$256K | ﹤0.01% | 951 |
|
|
2023
Q2 | $678K | Buy |
+142,401
| New | +$678K | 0.02% | 459 |
|